<DOC>
	<DOCNO>NCT01063751</DOCNO>
	<brief_summary>This study prospective , non-randomized evaluation Tritanium® Acetabular Shell primary total hip replacement ( THR ) cementless application consecutive series patient meet eligibility criterion . Half case use X3® polyethylene insert alone bear surface ; half use MDMTM liner couple compatible ADM/MDMTM X3® insert bear surface . The success rate , define freedom acetabular revision reason , hip implant Tritanium® Acetabular Shell , bad hip implant similar technology report literature Trident® X3® Study historical control 5 year postoperative .</brief_summary>
	<brief_title>Tritanium® Primary Acetabular Shell Study</brief_title>
	<detailed_description />
	<criteria>A . Patient sign IRB approve , study specific Informed Patient Consent Form . B . Patient male nonpregnant female age 18 year old time study device implantation . C. Patient primary diagnosis NonInflammatory Degenerative Joint Disease ( NIDJD ) . D. Patient candidate primary cementless total hip replacement . E. Patient willing able comply postoperative schedule clinical radiographic evaluation rehabilitation . F. Patient Body Mass Index ( BMI ) ≥ 40 . G. Patient active suspect latent infection affect hip joint time study device implantation . H. Patient neuromuscular neurosensory deficiency , limit ability evaluate safety efficacy device . I . Patient diagnose systemic disease ( e.g . Lupus Erythematosus ) metabolic disorder ( e.g . Paget 's Disease ) lead progressive bone deterioration . J . Patient immunologically suppress receive steroid excess normal physiological requirement ( e.g . &gt; 30 day ) . K. Patient require revision surgery previously implant total hip replacement hip fusion affect joint . L. Patient know sensitivity device material . M. Patient prisoner .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Traumatic arthritis</keyword>
	<keyword>Avascular Necrosis</keyword>
</DOC>